Literature DB >> 28360573

Late-life Onset Mania After Varenicline Use: A Case Report.

Abdullah Akpinar1, Gülin Özdamar Ünal1, İnci Meltem Atay1, Duru Gündoğar1, Ramazan Özçankaya1.   

Abstract

Late-life onset manic attacks generally occur secondary to general medical conditions or drug use. Varenicline is an α4β2 nicotinic acetylcholine receptor partial agonist, used for the cessation of smoking. In this case report, we present a 67-year-old male patient with a new-onset manic episode following varenicline treatment. The patient's manic symptoms started on the seventh day of varenicline treatment. His symptoms started on the 7th day of treatment. He was admitted to the psychiatric outpatient clinic since his symptoms did not improve despite discontinuing varenicline treatment. In the initial mental status examination, he scored 35/60 on the Young Mania Rating Scale (YMRS). On the twenty-fifth day of the hospitalization, the patient was discharged since his YMRS score improved (5/60). Varenicline may cause manic episodes in patients with bipolar disorder and in healthy individuals. An increasing number of serious psychiatric disorders are being reported due to varenicline treatment. Mental state examination before and during varenicline treatment seems necessary.

Entities:  

Keywords:  Varenicline; bipolar disorder; elderly; manic episode; psychiatry

Year:  2013        PMID: 28360573      PMCID: PMC5363432          DOI: 10.4274/npa.y6439

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  17 in total

1.  Varenicline-induced manic episode in a patient with bipolar disorder.

Authors:  Izchak Kohen; Neil Kremen
Journal:  Am J Psychiatry       Date:  2007-08       Impact factor: 18.112

2.  Exacerbation of schizophrenia by varenicline.

Authors:  Robert Freedman
Journal:  Am J Psychiatry       Date:  2007-08       Impact factor: 18.112

3.  Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission.

Authors:  Gholson J Lyon
Journal:  J Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.153

4.  Varenicline-induced mixed mood and psychotic episode in a patient with Schizoaffective Disorder.

Authors:  Mu-En Liu; Shih-Jen Tsai; Szu-Tung Yang
Journal:  CNS Spectr       Date:  2009-07       Impact factor: 3.790

5.  A case of late-life onset mania during Varenicline assisted smoking cessation.

Authors:  Dimitry Francois; Anna Odom; Nabil Kotbi
Journal:  Int J Geriatr Psychiatry       Date:  2011-06       Impact factor: 3.485

6.  Bipolar disorder: similarities and differences between patients with illness onset before and after 65 years of age.

Authors:  Osvaldo P Almeida; Stephen Fenner
Journal:  Int Psychogeriatr       Date:  2002-09       Impact factor: 3.878

7.  Varenicline-induced mania in a bipolar patient.

Authors:  Fadi Alhatem; James E Black
Journal:  Clin Neuropharmacol       Date:  2009 Mar-Apr       Impact factor: 1.592

Review 8.  The role of dopamine in bipolar disorder.

Authors:  David A Cousins; Kelly Butts; Allan H Young
Journal:  Bipolar Disord       Date:  2009-12       Impact factor: 6.744

9.  [Reliability and validity of Turkish translation of Young Mania Rating Scale].

Authors:  Figen Karadağ; Timuçin Oral; Füsun Aran Yalçin; Evrim Erten
Journal:  Turk Psikiyatri Derg       Date:  2002

10.  Varenicline for smoking cessation: A review of the literature.

Authors:  Kirandeep Kaur; Sandeep Kaushal; Sarvesh C Chopra
Journal:  Curr Ther Res Clin Exp       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.